These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4135062)

  • 1. [Albumin binding of the hepatotropic contrast medium Biligrafin].
    Pfab R
    Rontgenblatter; 1973 Jun; 26(6):282-6. PubMed ID: 4135062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of serum-binding capacity on the contrast media in the cholangiocystogram].
    Kölling K; Schoen D
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Sep; 113(3):372-5. PubMed ID: 5533871
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of the binding to human serum albumin of biliscopine (a new cholangiographic contrast medium) and five other contrast media.
    Mathieu J; Looze Y; Deconinck M
    Rofo; 1979 Apr; 130(4):418-20. PubMed ID: 155594
    [No Abstract]   [Full Text] [Related]  

  • 4. [The mechanisms of the interaction of contrast media with serum albumin and gamma-globulin studied by means of fluorescence extinction and equilibrium dialysis].
    Shabunin IV; Panov VO; Kalinina AA; Shimanovskiĭ NL; Sergeev PV
    Eksp Klin Farmakol; 1996; 59(5):43-6. PubMed ID: 9026210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Competitive interrelations between bilirubin and x-ray contrast agents in binding with human serum albumin].
    Shimanovskiĭ NL; Kuriashkin IV
    Farmakol Toksikol; 1986; 49(2):52-5. PubMed ID: 3709775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biligram--a new hepatotropic contrast medium for infusion cholecysto-cholangiography].
    Lazecki L
    Pol Przegl Radiol Med Nukl; 1972; 36(6):775-8. PubMed ID: 4660877
    [No Abstract]   [Full Text] [Related]  

  • 7. [The mechanisms of the interaction of sex hormones with serum albumin and gamma-globulins studied by the methods of equilibrium dialysis and fluorescence quenching].
    Karachentsev AN; Mel'chenko IA
    Eksp Klin Farmakol; 1997; 60(4):68-70. PubMed ID: 9376764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of oral anti-diabetic agents (suphonyle ureas) on the excretion of intravenous biliary contrast media (author's transl)].
    Klumair J; Pflanzer K
    Rofo; 1977 Jan; 126(1):66-9. PubMed ID: 137871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatotropic contrast media].
    Lazecki L
    Pol Przegl Radiol Med Nukl; 1972; 36(1):63-9. PubMed ID: 5012373
    [No Abstract]   [Full Text] [Related]  

  • 10. [First comparative radiologic studies between "bilivistan" (a new contrast media for cholangio-cholecystography) and "biligrafin"].
    Miceli R
    Ann Radiol Diagn (Bologna); 1965; 38(3):239-65. PubMed ID: 5864226
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infusion cholangiography. I. Pathophysiological basis].
    Zgliczynski SL; Lazecki L
    Pol Przegl Radiol Med Nukl; 1971; 35(1):57-61. PubMed ID: 5553877
    [No Abstract]   [Full Text] [Related]  

  • 12. [Equilibrium dialysis for the determination of relative serum binding capacity of a roentgen contrast medium].
    Kölling K; Schoen D
    Med Welt; 1972 Mar; 23(12):410-1. PubMed ID: 5037181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of cholecystography and cholangiography on the activity of some serum enzymes and their urinary excretion].
    Szewczyk Z; Skiba W; Klimkiewicz E; Moroń K
    Pol Tyg Lek; 1975 Jun; 30(24):1017-20. PubMed ID: 1144171
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of folic acid to serum proteins. IV In some animal species.
    Markkanen T; Pajula RL; Himanen P; Virtanen S
    Int J Vitam Nutr Res; 1974; 44(3):347-56. PubMed ID: 4142481
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal catabolism of albumin in the nephrotic syndrome.
    Jensen H
    Dan Med Bull; 1971 May; 18(2):25-33. PubMed ID: 4105317
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction of 125I-omnipaque with the rat mononuclear phagocytes].
    Sergeev PV; Shabunin IV; Shimanovskiĭ NL; Panov VO
    Biull Eksp Biol Med; 1999 Oct; 128(10):400-2. PubMed ID: 10599494
    [No Abstract]   [Full Text] [Related]  

  • 17. Competitive action of contrast media on the uric acid-albumin binding.
    Boldrini E; Tirone P
    J Pharmacol Methods; 1982 Jan; 7(1):1-6. PubMed ID: 7070100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differences between Bilivistan and Biligrafin in intravenous cholangiocholecystography].
    Gollmann G; Gasperlmair J; Hammer B
    Med Welt; 1967 Feb; 8():442-5. PubMed ID: 6044566
    [No Abstract]   [Full Text] [Related]  

  • 19. The extraordinary ligand binding properties of human serum albumin.
    Fasano M; Curry S; Terreno E; Galliano M; Fanali G; Narciso P; Notari S; Ascenzi P
    IUBMB Life; 2005 Dec; 57(12):787-96. PubMed ID: 16393781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution to the problem of hepatotoxic tropic contrast substances during cholangiocholecystography (author's transl)].
    Bruna J; Bártek R
    Cesk Radiol; 1975 Mar; 29(2):108-14. PubMed ID: 1132053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.